Saudi Arabia Neurology Devices Market Trends

A neurostimulation device is programmed to continuously monitor electrophysiological signals that are precursors to seizure activity. The fast growth of the segment is due to the increasing use of sacral nerve stimulation devices and deep brain stimulation devices. Deep brain stimulation devices are generally used to treat neuropsychiatric disorders and are effectively used in treating other neurological disorders, like Parkinson's disease, essential tremor, dystonia, chronic pain, major depression, and obsessive-compulsive disorder. The treatment of other neurological diseases like rain tumors and spinal cord injuries also boosts the growth of the segment.

As per a study, 'Evaluation of knowledge of Alzheimer's disease among health university students in Riyadh, Saudi Arabia,' published in August 2020, the prevalence of dementia in Saudi Arabia was estimated to be around 6.4%. Factors such as age, low level of education, hypertension, and cardiovascular diseases were risk factors for cognitive impairment. As per a January 2020 published article titled 'The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review,' migraine prevalence among the general population ranged between 2.6% and 32%. As per the same source, the estimated prevalence of migraine headaches among medical university students ranged between 12.2% and 27.9% and between 7.1% and 13.7% in schoolchildren (6 to 18 years). These statistics indicate the significant need for neurofeedback systems, as they can reduce the occurrence of migraine or reduce the pain. Hence, with the increasing incidence of migraine, the demand for neurostimulation devices will grow in the coming years.